Lei Mei Pharmaceutical: Guangtou Jin Kong will change to become the company's indirectly controlling shareholder.

Lai Mei Pharmaceutical announced that its indirect controlling shareholder, Guangtou Group, plans to increase the capital and expand the shares of Guangtou Financial Control by using the 859 million shares of Zhongheng Group it holds. After this transaction is completed, Guangtou Financial Control will become the indirect controlling shareholder of the company, while Zhongheng Group will remain the direct controlling shareholder and the Guangxi State-owned Assets Supervision and Administration Commission will remain the actual controller of the company. This transaction will not change Zhongheng Group's control over the company, nor will it have any impact on the company's normal production and operation activities.